Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NVUSPH · Entity 379 | Director · Chairman of the Board and CEO | February 23, 2026 | February 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
U S PHYSICAL THERAPY INC /NV
Report date February 23, 2026 · Filed February 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 139,088 |
Reported balance
After 2026-02-23 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-23 · Grant · Acquired 25,000 · Balance 139,088 F1: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. The restrictions lapse in 15 equal quarterly installments of 1,562 shares beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each of the years 2026, 2027, 2028, and 2029 and 1,570 shares vesting on March 6, 2030 F2: Includes 54,946 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 4,152 shares vest on March 6, 2026; 4,464 shares vest on each of May 20, 2026, August 20, 2026, November 20, 2026 and March 6, 2027; 3,839 shares vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 3,847 shares vest on March 6, 2028; 2,827 shares vest on each of May 20, 2028, August 20, 2028, and November 20, 2028; 2,837 shares vest on March 6, 2029; 1,562 shares vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 1,570 shares vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. The restrictions lapse in 15 equal quarterly installments of 1,562 shares beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each of the years 2026, 2027, 2028, and 2029 and 1,570 shares vesting on March 6, 2030
F2: Includes 54,946 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 4,152 shares vest on March 6, 2026; 4,464 shares vest on each of May 20, 2026, August 20, 2026, November 20, 2026 and March 6, 2027; 3,839 shares vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 3,847 shares vest on March 6, 2028; 2,827 shares vest on each of May 20, 2028, August 20, 2028, and November 20, 2028; 2,837 shares vest on March 6, 2029; 1,562 shares vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 1,570 shares vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2026 Filed Feb 26, 2026 01:46 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-072717 · ownership.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,088 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. The restrictions lapse in 15 equal quarterly installments of 1,562 shares beginning on May 20, 2026 and on each of March 6, May 20, August 20, and November 20 of each of the years 2026, 2027, 2028, and 2029 and 1,570 shares vesting on March 6, 2030 F2 · balance_after: Includes 54,946 shares, inclusive of those mentioned in Footnote 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restriction lapse as follows: 4,152 shares vest on March 6, 2026; 4,464 shares vest on each of May 20, 2026, August 20, 2026, November 20, 2026 and March 6, 2027; 3,839 shares vest on each of May 20, 2027, August 20, 2027, and November 20, 2027; 3,847 shares vest on March 6, 2028; 2,827 shares vest on each of May 20, 2028, August 20, 2028, and November 20, 2028; 2,837 shares vest on March 6, 2029; 1,562 shares vest on each of May 20, 2029, August 20, 2029, and November 20, 2029 and 1,570 shares vest on March 6, 2030. Vesting is subject to his continued employment with the Company through each applicable vesting date. Read SEC document |
| September 04, 2025 Filed Sep 5, 2025 20:15 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,000 | $83.53 | $167,060.00 |
DisclosureSEC source: 0000950170-25-113254 · ownership.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,088 F1 · balance_after: Includes 34,098 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 4,152 shares on each of November 20, 2025 and March 6, 2026, 2,902 shares on each of May 20, 2026, August 20, 2026, November 20, 2026, and March 6, 2027, 2,277 shares on each of May 20, 2027, August 20, 2027, and November 20, 2027, 2,285 shares on March 6, 2028,1,265 shares on each of May 20, 2028, August 20, 2028, and November 20, 2028, and 1,275 shares on March 6, 2029, if he is an employee of the Company on those dates. Read SEC document |
| February 24, 2025 Filed Feb 27, 2025 01:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 20,250 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-028168 · ownership.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,088 F1 · shares: These shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal quarterly installments of 1,265 shares vesting on each of May 20, August 20, November 20 of 2025 and March 6, May 20, August 20 and November 202 in each year 2026, 2027 and 2028, with the final 1,275 shares vesting on March 6, 2029, if he is employed by the Company on those dates. F2 · balance_after: Includes the shares in footnote 1 and 22,152 shares described in next sentences. On February 24, 2025, the issuer and the reporting person mutually agreed to amend the vesting terms of the outstanding awards. Per the amendment, of the total outstanding unvested shares of 22,152, 2,887 will vest on May 20, 2025, 2,887 will vest on each August 20, 2025 and November 20, 2025, 2,887 will vest on March 6, 2026, 1,637 will vest on each of May 20, 2026, August 20, 2026 and November 20, 2026, and March 6, 2027, 1,012 will vest on each of May 20, 2027, August 20, 2027, November 2027 and 1,020 will vest on March 6, 2028, if he is employed on those dates. Read SEC document |
| May 30, 2024 Filed May 31, 2024 22:00 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,900 | $100.26 | $290,754.00 |
DisclosureSEC source: 0000950170-24-067492 · ownership.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,838 F1 · price: The price reported ($100.26) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $100.00 to $100.90 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 32,913 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 3,587 shares on each of July 1, 2024 and October 1, 2024; 3,588 shares on January 1, 2025; 2,887 shares on each April 1, 2025, July 1, 2025, and on October 1, 2025; 2,888 shares on January 1, 2026; 1,637 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 1,638 shares on January 1, 2027; and 1,012 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 1,017 shares on January 1, 2028, if he is an Officer of the Company on those dates. Read SEC document |
| May 29, 2024 Filed May 29, 2024 21:27 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $100.13 | $100,130.00 |
DisclosureSEC source: 0000950170-24-066088 · ownership.xml · nonDerivative · entry 2 READING CHRISTOPHER J · CIK 0001270356 · Director · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,738 F1 · price: For the transaction executed on May 28, 2024, the price reported ($102.13) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $102.00 to $102.26 per share, both inclusive. For the transaction executed on May 29, 2024, the price reported ($100.13) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $100.00 to $100.49 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 32,913 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 3,587 shares on each of July 1, 2024 and October 1, 2024; 3,588 shares on January 1, 2025; 2,887 shares on each April 1, 2025, July 1, 2025, and on October 1, 2025; 2,888 shares on January 1, 2026; 1,637 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 1,638 shares on January 1, 2027; and 1,012 shares on each of April 1, 2027, July 1, 2027, October 1, 2027; and 1,017 shares on January 1, 2028, if he is an Officer of the Company on those dates. Read SEC document |
| May 28, 2024 Filed May 29, 2024 21:27 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,100 | $102.13 | $112,343.00 |
DisclosureSEC source: 0000950170-24-066088 · ownership.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chairman of the Board and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,738 F1 · price: For the transaction executed on May 28, 2024, the price reported ($102.13) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $102.00 to $102.26 per share, both inclusive. For the transaction executed on May 29, 2024, the price reported ($100.13) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $100.00 to $100.49 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| February 26, 2024 Filed Feb 29, 2024 01:28 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 16,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-022521 · ownership.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,838 F1 · shares: Includes 16,200 shares, inclusive of those shares mentioned in note1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 15 equal installments with the first 1,012 shares on April 1, 2024 and thereafter with 1,012 shares on April 1, July 1, October 1 and Janaury 1 of each year with the final 1,017 shares lapsing on Janaury 1, 2028, if he is employed by the Company on those dates. F2 · balance_after: Includes 36,500 shares, inclusive of those shares mentioned in Note 1, which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 3,587 shares on each of April 1, 2024, July 1, 2024 and October 1, 2024; 3,588 shares on January 1, 2025; 2,887 shares on each of April 1, 2025, July 1, 2024, October 1, 2025; 2,888 shares on January 1, 2026; 1,637 shares on each of April 1, 2026, July 1, 2026, October 1, 2026; 1,638 shares on January 1, 2027; and 1012 shares on each of April 1, 2027, July 1, 2026, October 1, 2027; and 1,017 shares on January 1, 2028, if he is an employee of the Company on those dates. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 21:40 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012213 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,638 F1 · shares: The 10,000 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 equal quarterly installments with the first 625 shares vesting on April 1, 2023 and with the final 625 shares vesting on January 1, 2027, if he is employed by the Company on those dates. F2 · balance_after: Includes 34,204 shares which were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 3,473 shares on each of April 1, 2023, July 1, 2023 and October 1, 2023; 3,485 shares on January 1, 2024; 2,575 shares on each of April 1, 2024, July 1, 2024, October 1, 2024 and January 1, 2025; 1,875 shares on each of April 1, 2025, July 1, 2025, October 1, 2025; and January 1, 2026; and 625 shares on each of April 1, 2026, July 1, 2026, October 1, 2026 and January 1, 2027, if he is an employee of the Company on those dates. Read SEC document |
| December 05, 2022 Filed Dec 7, 2022 19:56 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 5,000 | $90.00 | $450,000.00 |
DisclosureSEC source: 0001209191-22-060139 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,638 F1 · balance_after: Includes 28,333 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 4,129 shares on January 1, 2023; 2,848 shares on each of April 1, July 1 and October 1, 2023; 2,860 shares on January 1, 2024; 1,950 shares on each of April 1, July 1 and October 1, 2024, and on January 1, 2025; and 1,250 shares on each of April 1, July 1 and October 1, 2025, and on January 1, 2026, if he is an employee of the Company on those dates. Read SEC document |
| December 02, 2022 Filed Dec 5, 2022 20:28 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon stock | 10,000 | $90.01 | $900,100.00 |
DisclosureSEC source: 0001209191-22-059618 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,638 F1 · price: The price reported is a weighted average price $90.01. The shares were sold in multiple transactions at prices ranging from $90.00 to $90.44 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 28,333 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 4,129 shares on January 1, 2023; 2,848 shares on each of April 1, July 1 and October 1, 2023; 2,860 shares on January 1, 2024; 1,950 shares on each of April 1, July 1 and October 1, 2024, and on January 1, 2025; and 1,250 shares on each of April 1, July 1 and October 1, 2025, and on January 1, 2026, if he is an employee of the Company on those dates. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 13:55 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-018693 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,638 F1 · shares: The 20,000 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 equal quarterly installments with the first 1,250 shares on April 1, 2022 and with the final 1,250 shares lapsing on January 1, 2026, if he is employed by the Company on those dates. F2 · balance_after: Includes the 20,000 shares in Footnote 1 and includes 20,711 shares which restrictions lapse as to 2,876 on each of April 1, July 1 and October 1, 2022; 2,879 shares on January 1, 2023; 1,598 shares on each of April 1, July 1 and October 1, 2023; 1,610 shares on January 1, 2024; and 700 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates. Read SEC document |
| December 17, 2021 Filed Dec 20, 2021 18:02 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 12,000 | $93.89 | $1,126,680.00 |
DisclosureSEC source: 0001209191-21-070494 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,638 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $93.75 - $94.00, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 24,852 shares which restrictions lapse as to 4,141 on January 1, 2022; 2,876 on each of April 1, July 1 and October 1, 2022; 2,879 shares on January 1, 2023; 1,598 shares on each of April 1, July 1 and October 1, 2023; 1,610 shares on January 1, 2024; and 700 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 17:16 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 11,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013683 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,638 F1 · shares: The 11,200 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan of which 8,800 under the Companys Discretionary Long-Term Incentive Plan for Senior Management and 2,400 as an additional grant. Restrictions lapse in 16 equal quarterly installment with the first 700 shares on April 1, 2021 and thereafter with 700 shares on April 1, July 1, October 1 and January 1 of each year with the final 700 shares lapsing on January 1, 2025, if he is employed by the Company on those dates. F2 · balance_after: Inclusive of the above 11,200 shares in footnote 1, includes 37,275 shares which restrictions lapse as to 4,141 shares on each of April 1, July 1 and October 1, 2021 and January 1, 2022; 2,876 on each of April 1, July 1 and October 1, 2022; 2,879 shares on January 1, 2023; 1,598 shares on each of April 1, July 1 and October 1, 2023; 1,610 shares on January 1, 2024; and 700 shares on each of April 1, July 1 and October 1, 2023 and January 1, 2025, if he is employed by the Company on those dates. Read SEC document |
| December 04, 2020 Filed Dec 4, 2020 21:56 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 6,000 | $106.67 | $640,020.00 |
DisclosureSEC source: 0001209191-20-061820 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,438 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $105.64 - $107.60, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 30,551 shares which restrictions lapse as to 4,476 shares on January 1, 2021; 3,441 shares on each of April 1, July 1 and October 1, 2021 and January 1, 2022; 2,176 shares on each of April 1, July 1 and October 1, 2022; 2,179 shares on January 1, 2023; 898 shares on each of April 1, July 1 and October 1 2023 and 910 shares on January 1, 2024, if he is employed on those dates. Read SEC document |
| March 03, 2020 Filed Mar 5, 2020 19:22 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 14,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016492 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,438 F1 · shares: The 14,380 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 equal quarterly installment with the 898 shares on April 1, 2020 and thereafter with 898 shares on April 1, July 1, October 1 and January 1 of each year with the final 910 shares lapsing on January 1, 2024. F2 · balance_after: Includes 43,937 shares which restrictions lapse as to 4,462 shares on each of April 1, July 1 and October 1, 2020; 4,476 shares on January 1, 2021; 3,441 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 2,176 shares on each of April 1, July 1 and October 1, 2022; 2,179 shares on January 1, 2023; 898 shares on each of April 1, July 1 and October 1 2023 and 910 shares on January 1, 2024. Read SEC document |
| August 19, 2019 Filed Aug 19, 2019 22:21 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 4,899 | $135.12 | $661,952.88 |
DisclosureSEC source: 0001209191-19-046692 · doc4.xml · nonDerivative · entry 3 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,058 F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $134.77 to $135.51 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 39,525 shares which restrictions lapse as to 4,984 shares on each of October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023 Read SEC document |
| August 16, 2019 Filed Aug 19, 2019 22:21 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,500 | $135.07 | $202,605.00 |
DisclosureSEC source: 0001209191-19-046692 · doc4.xml · nonDerivative · entry 2 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,957 F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.00 to $135.31 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 39,525 shares which restrictions lapse as to 4,984 shares on each of October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023 Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 22:21 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 601 | $135.39 | $81,369.39 |
DisclosureSEC source: 0001209191-19-046692 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,457 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $135.06 to $136.22 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 39,525 shares which restrictions lapse as to 4,984 shares on each of October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023 Read SEC document |
| May 21, 2019 Filed May 22, 2019 19:43 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 9,860 | $120.52 | $1,188,327.20 |
DisclosureSEC source: 0001209191-19-032020 · doc4.xml · nonDerivative · entry 2 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,058 F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $120.00 to $120.91 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 44,509 shares which restrictions lapse as to 4,984 shares on each of July 1, 2019, October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023. Read SEC document |
| May 20, 2019 Filed May 22, 2019 19:43 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 10,000 | $118.22 | $1,182,200.00 |
DisclosureSEC source: 0001209191-19-032020 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,918 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.00 to $118.60 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 44,509 shares which restrictions lapse as to 4,984 shares on each of July 1, 2019, October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023. Read SEC document |
| March 04, 2019 Filed Mar 5, 2019 22:12 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 20,451 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016719 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,918 F1 · shares: The 20,451 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 equal quarterly installment with the 1,278 shares on April 1, 2019 and thereafter with 1,278 on April 1, July 1, October 1 and January 1 of each year with the final 1,281 shares lapsing on January 1, 2023. F2 · balance_after: Includes 49,493 shares, inclusive of the 20,451 shares in footnote 1, of restricted stock granted under the Company's equity plans. Restrictions lapse as to 4,984 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020; 3,564 shares on each of April 1, July 1 and October 1, 2020; 3,578 shares on January 1, 2021; 2,543 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022; 1,278 on each of April 1, July 1 and October 1, 2022; and 1,281 on January 1, 2023. Read SEC document |
| August 14, 2018 Filed Aug 15, 2018 19:31 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 8,768 | $115.57 | $1,013,317.76 |
DisclosureSEC source: 0001209191-18-046737 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,467 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.00 - $116.65, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 41,454 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,206 shares on each of October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022. Read SEC document |
| August 07, 2018 Filed Aug 8, 2018 19:18 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 451 | $115.78 | $52,216.78 |
DisclosureSEC source: 0001209191-18-045799 · doc4.xml · nonDerivative · entry 2 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,235 F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.40 - $116.50, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 41,454 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,206 shares on each of October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022. Read SEC document |
| August 06, 2018 Filed Aug 8, 2018 19:18 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 781 | $116.58 | $91,048.98 |
DisclosureSEC source: 0001209191-18-045799 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,686 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.50 - $117.35, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 41,454 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,206 shares on each of October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022. Read SEC document |
| May 11, 2018 Filed May 11, 2018 19:51 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,672 | $92.16 | $246,251.52 |
DisclosureSEC source: 0001209191-18-029508 · doc4.xml · nonDerivative · entry 3 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,467 F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.60, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 47,660 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,206 shares on each of July 1, 2018, October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022. Read SEC document |
| May 10, 2018 Filed May 11, 2018 19:51 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 8,689 | $92.05 | $799,822.45 |
DisclosureSEC source: 0001209191-18-029508 · doc4.xml · nonDerivative · entry 2 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,139 F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.40, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 47,660 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,206 shares on each of July 1, 2018, October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022. Read SEC document |
| May 09, 2018 Filed May 11, 2018 19:51 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 13,639 | $92.01 | $1,254,924.39 |
DisclosureSEC source: 0001209191-18-029508 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,828 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $92.00 - $92.10, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 47,660 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,206 shares on each of July 1, 2018, October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022. Read SEC document |
| March 09, 2018 Filed Mar 13, 2018 18:55 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 12,000 | $86.57 | $1,038,840.00 |
DisclosureSEC source: 0001209191-18-019085 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,467 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $86.38 - $86.95, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 53,866 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,206 shares on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 3,706 shares on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: 2,286 shares on each of April 1, July 1 and October 1, 2020; 2,300 shares on January 1, 2021; and 1,265 shares on each of April 1, July 1 and October 1, 2021 and on January 1, 2022. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 19:45 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 20,240 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-017653 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,467 F1 · shares: The 20,240 shares of common stock were granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 quarterly installments of 1,265 shares each beginning on April 1, 2018 and thereafter on April 1, July 1, October 1 and January 1 of each year with the final 1,265 shares lapsing on January 1, 2022. F2 · balance_after: Includes the above mentioned shares and 33,626 of restricted stock granted under the Company's equity plans. Restrictions lapse as to 4,941 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 2,441 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: $1,021 on each of April 1, July 1 and October 1, 2020; and $1,035 on January 1, 2021. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 17:38 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 15,000 | $66.52 | $997,800.00 |
DisclosureSEC source: 0001209191-17-059924 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,227 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.20- $66.95, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 40,442 of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,816 shares on January 1, 2018; 4,941 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 2,441 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: $1,021 on each of April 1, July 1 and October 1, 2020; and $1,035 on January 1, 2021. Read SEC document |
| March 24, 2017 Filed Mar 28, 2017 15:07 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 16,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-023051 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,227 F1 · shares: The 16,350 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse in 16 quarterly installment with the first 15 installments of 1,021 shares each beginning on April 1, 2017 and thereafter with 1,021 on April 1, July 1, October 1 and January 1 of each year with the final 1,035 shares lapsing on January 1, 2021. F2 · balance_after: Includes the 16,350 shares recently granted and 44,540 of restricted stock granted under the Company's equity plans. Restrictions lapse as to 6,816 on each of April 1, 2017, July 1, 2017, October 1, 2017 and January 1, 2018; 4,941 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; 2,441 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020: $1,021 on each of April 1, July 1 and October 1, 2020; and $1,035 on January 1, 2021. Read SEC document |
| September 19, 2016 Filed Sep 19, 2016 21:47 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 8,000 | $64.01 | $512,080.00 |
DisclosureSEC source: 0001209191-16-142057 · doc4.xml · nonDerivative · entry 1 READING CHRISTOPHER J · CIK 0001270356 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,877 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $64.00 - $64.11, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 60,730 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 8095 shares on October 1, 2016, January 1, 2017; 5795 on each of April 1, 2017, July 1, 2017, October 1, 2017 and January 1, 2018; 3920 on each of April 1, 2018, July 1, 2018, October 1, 2018 and January 1, 2019; and 1420 on each of April 1, 2019, July 1, 2019, October 1, 2019 and January 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.